Document is current
Any future updates will be listed below
-
Authors
Leslie, Jonah http://orcid.org/0000-0003-2208-4658
Kiweewa, Flavia
Palanee-Phillips, Thesla
Bunge, Katherine
Mhlanga, Felix
Kamira, Betty
Baeten, Jared
Katz, Ariana
Hillier, Sharon
Montgomery, Elizabeth
Baeten, Jared
Palanee-Phillips, Thesla
Brown, Elizabeth
Soto-Torres, Lydia
Schwartz, Katie
Makanani, Bonus
Martinson, Francis
Bekker, Linda-Gail
Govender, Vaneshree
Siva, Samantha
Gaffoor, Zakir
Naidoo, Logashvari
Pather, Arendevi
Jeenarain, Nitesha
Nair, Gonasagrie
Palanee-Phillips, Thesla
Matovu, Flavia
Mgodi, Nyaradzo
Mhlanga, Felix
,
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01617096 at ClinicalTrials.govDocuments that mention this clinical trial
Vaginal Ring Use in a Phase 3 Microbicide Trial: A Comparison of Objective Measures and Self-reports of Non-adherence in ASPIRE
https://doi.org/10.1007/s10461-018-2261-8
Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial
https://doi.org/10.1007/s10461-021-03205-z
Experiences with simultaneous use of contraception and the vaginal ring for HIV prevention in sub-Saharan Africa
https://doi.org/10.1186/s12905-021-01321-5
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (UM1AI068633, UM1AI068615, UM1AI106707)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
- License Information
-
More Information
Article History
Received: 18 September 2020
Accepted: 19 April 2021
First Online: 23 April 2021
Declarations
:
: The study was approved by the following Institutional Review Boards/Ethics Committees and Drug Regulatory Authorities: Prevention Sciences Research Committee of the US National Institute of Allergy and Infectious Diseases; US Food and Drug Administration; National Health Sciences Research Committee of Malawi; University of North Carolina at Chapel Hill Institutional Review Board; Pharmacy, Medicines and Poisons Board of Malawi; University of Cape Town: Human Research Ethics Committee; South African Medical Research Council Ethics Committee; Human Research Ethics Committee: (Medical), University of Witwatersrand, Johannesburg; Medicines Control Council of South Africa; Joint Clinical Research Centre Institutional Review Board; Uganda National Council for Science and Technology; Johns Hopkins University School of Medicine Institutional Review Board; National Drug Authority of Uganda; Medical Research Council of Zimbabwe; Committee on Human Research, University of California—San Francisco; Joint Parirenyatwa Hospital and College of Health Sciences Research Ethics; Research Council of Zimbabwe; Medicines Control Authority of Zimbabwe. All participants provided written informed consent.
: Not applicable.
: The authors declare that they have no competing interests.
